Chemoinformaics analysis of Dihydrocycloartomunin
| Molecular Weight | 450.487 | nRot | 4 |
| Heavy Atom Molecular Weight | 424.279 | nRig | 24 |
| Exact Molecular Weight | 450.168 | nRing | 4 |
| Solubility: LogS | -3.208 | nHRing | 2 |
| Solubility: LogP | 5.696 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 66.3706 |
| nHD | 3 | BPOL | 32.1594 |
| QED | 0.356 |
| Synth | 3.874 |
| Natural Product Likeliness | 2.309 |
| NR-PPAR-gamma | 0.911 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.612 |
| Pgp-sub | 0.985 |
| HIA | 0.276 |
| CACO-2 | -4.928 |
| MDCK | 0.00000953 |
| BBB | 0.002 |
| PPB | 0.800869 |
| VDSS | 0.8 |
| FU | 0.167499 |
| CYP1A2-inh | 0.237 |
| CYP1A2-sub | 0.704 |
| CYP2c19-inh | 0.863 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.885 |
| CYP2c9-sub | 0.932 |
| CYP2d6-inh | 0.42 |
| CYP2d6-sub | 0.263 |
| CYP3a4-inh | 0.194 |
| CYP3a4-sub | 0.148 |
| CL | 3.507 |
| T12 | 0.321 |
| hERG | 0.004 |
| Ames | 0.671 |
| ROA | 0.667 |
| SkinSen | 0.534 |
| Carcinogencity | 0.043 |
| EI | 0.713 |
| Respiratory | 0.688 |
| NR-Aromatase | 0.957 |
| Antiviral | Yes |
| Prediction | 0.780269 |